Vista Current Coverage

All Healthcare/Biotech Articles

San Diego-based Fate Therapeutics Enters Strategic Collaboration with Tokyo’s ONO Pharmaceutical Co.

San Diego-based Fate Therapeutics (Nasdaq: FATE) is a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders. The Company is pioneering the development of off-the-shelf cell therapies using its proprietary induced pluripotent stem cell (iPSC) product platform. The Company’s immuno-oncology...

Check out the Programmable Shape-shifting Metal

Scientists at the University of Sussex and Swansea University have created a programmable, shape-shifting metal. Sounds unreal? The unreal sounding breakthrough is very real! Scientists use electrical charges, apply to liquid metal, and coax it into 3D shapes. This new, extremely promising material can be...

Breast Cancer Innovator Atossa Genetics Has Added Alchem Laboratories As Second Manufacturer to Supply “Increasing Need” Of Endoxifen

Seattle-based Atossa Genetics Inc. (NASDAQ: ATOS) a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions, announced this week that is has added Alchem Laboratories as a U.S. contract manufacturer to supply Endoxifen. Subject to successful bioequivalence...